Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Mont’Alverne, F. Articles by Chiras, J. Search for Related Content PubMed PubMed Citation Articles by Mont’Alverne, F. Articles by Chiras, J.

American Journal of Neuroradiology 26:1641-1645, August 2005
© 2005 American Society of Neuroradiology

SPINE

Percutaneous Vertebroplasty for Metastatic Involvement of the Axis

Francisco Mont’Alverne^a, Jean-Noel Vallée^a, Evelyne Cormier^a, Remy Guillevin^a, Hector Barragan^a, Betty Jean^a, Michelle Rose^a and Jacques Chiras^a

^a From the Department of Neuroradiology, Groupe Hospitalier Pitie-Salpetriere, Paris, France

Address correspondence to Francisco Mont’Alverne, Department of Neuroradiology, Groupe Hospitalier Pitie-Salpetriere, Paris, France

BACKGROUND AND PURPOSE: Percutaneous vertebroplasty in the upper cervical spine is a challenging procedure, and little is known about its therapeutic outcome. The purpose of this study was to assess the risks and benefits of percutaneous vertebroplasty for metastatic involvement of the axis.

METHODS: From January 1994 to August 2004, 12 patients (mean age, 52.3 years) underwent percutaneous vertebroplasty via an anterolateral approach using fluoroscopic guidance for metastatic lesions involving the C2 vertebral body; pain intensity was scored on a scale ranging from 0.0 (no pain) to 10.0 (maximum pain intensity). Eight patients (66.7%) were followed up (mean, 6.9 months); 5 of them had percutaneous vertebroplasty indicated for pain control and spine stabilization and 3, for spine stabilization only.

RESULTS: The mean volume of cement injected was 2.9 ± 0.7 mL (range, 2.0–4.0 mL) with a mean vertebral filling of 60.7 ± 14.6% (range, 25–80%). Cement leakage was detected in 7 treated vertebrae (58.3%). Pain improvement was achieved in 4/5 patients (80%). Spine stability was observed in 7 patients (87.5%), but 1 patient (12.5%) presented with a secondary spine deformity in association with partial vertebral filling. Two postprocedural clinical manifestations (16.7%) were observed: 1 patient (8.3%) had a transient occipital neuralgia and another (8.3%) had an ischemic stroke. Mortality and morbidity rates at mean follow-up were 0.0% and 12.5% (1 patient), respectively.

CONCLUSION: Percutaneous vertebroplasty of C2 metastases by an antero-lateral approach is an effective option in the treatment strategy of patients with metastases to C2. Nevertheless, it is a challenging procedure and may carry regional and even intracranial risks due to the proximity to the vertebral artery.

This article has been cited by other articles:

				G. Christoforidis, D. Dang, and J. Gabriel Catheter-directed percutaneous transpedicular c2/c3 vertebroplasty in a patient with fibrous dysplasia using seldinger technique. AJNR Am. J. Neuroradiol., September 1, 2006; 27(8): 1738 - 1740. [Abstract] [Full Text] [PDF]